NSRX nasuspharma.com Year-over-year earnings per share growth for the last twelve months

Nasus Pharma Ltd (NSRX) is driving revenue growth through the monetization of nasal sprays, which is why the quarterly EPS growth trend on GURU.Markets includes the latest -356.40 parameter. This growth is based on streamlined temperature-controlled hub logistics and management's focus on developing rapid-response products for emergency medicine. Such systemic solutions minimize supply chain disruptions and strengthen the issuer's market position.
NSRX (Nasus Pharma): analytical breakdowns and indicator data

This indicator measures the dynamics of net earnings per share, eliminating temporary gaps between reporting periods through a daily calculation of growth. The current quarterly earnings per share growth value is -356.40, where any trend deceleration could foreshadow a decline in the capitalization of Nasus Pharma Ltd (NSRX) due to the dependence of profits on the efficiency of nasal drug delivery systems.